Santoni-Rugiu E - Search Results

1

MMSET is highly expressed and associated with aggressiveness in neuroblastoma.

Hudlebusch HR, Skotte J, Santoni-Rugiu E, Zimling ZG, Lees MJ, Simon R, Sauter G, Rota R, De Ioris MA, Quarto M, Johansen JV, Jørgensen M, Rechnitzer C, Maroun LL, Schrøder H, Petersen BL, Helin K. Hudlebusch HR, et al. Cancer Res. 2011 Jun 15;71(12):4226-35. doi: 10.1158/0008-5472.CAN-10-3810. Epub 2011 Apr 28. Cancer Res. 2011. PMID: 21527557

2

Conditional E2F1 activation in transgenic mice causes testicular atrophy and dysplasia mimicking human CIS.

Agger K, Santoni-Rugiu E, Holmberg C, Karlström O, Helin K. Agger K, et al. Oncogene. 2005 Jan 27;24(5):780-9. doi: 10.1038/sj.onc.1208248. Oncogene. 2005. PMID: 15531911

3

The histone methyltransferase and putative oncoprotein MMSET is overexpressed in a large variety of human tumors.

Hudlebusch HR, Santoni-Rugiu E, Simon R, Ralfkiær E, Rossing HH, Johansen JV, Jørgensen M, Sauter G, Helin K. Hudlebusch HR, et al. Clin Cancer Res. 2011 May 1;17(9):2919-33. doi: 10.1158/1078-0432.CCR-10-1302. Epub 2011 Mar 8. Clin Cancer Res. 2011. PMID: 21385930

4

Expression of C4.4A in precursor lesions of pulmonary adenocarcinoma and squamous cell carcinoma.

Jacobsen B, Santoni-Rugiu E, Illemann M, Kriegbaum MC, Laerum OD, Ploug M. Jacobsen B, et al. Int J Cancer. 2012 Jun 1;130(11):2734-9. doi: 10.1002/ijc.26305. Epub 2011 Aug 24. Int J Cancer. 2012. PMID: 21792890 Free article.

5

Low ERCC1 expression in malignant pleural mesotheliomas treated with cisplatin and vinorelbine predicts prolonged progression-free survival.

Zimling ZG, Sørensen JB, Gerds TA, Bech C, Andersen CB, Santoni-Rugiu E. Zimling ZG, et al. J Thorac Oncol. 2012 Jan;7(1):249-56. doi: 10.1097/JTO.0b013e318233d6a9. J Thorac Oncol. 2012. PMID: 22031231 Free article.

6

The diagnostic value of immunohistochemically detected methylthioadenosine phosphorylase deficiency in malignant pleural mesotheliomas.

Zimling ZG, Jørgensen A, Santoni-Rugiu E. Zimling ZG, et al. Histopathology. 2012 May;60(6B):E96-105. doi: 10.1111/j.1365-2559.2012.04196.x. Epub 2012 Mar 6. Histopathology. 2012. PMID: 22394205

7

A biomarker profile for predicting efficacy of cisplatin-vinorelbine therapy in malignant pleural mesothelioma.

Zimling ZG, Sørensen JB, Gerds TA, Bech C, Andersen CB, Santoni-Rugiu E. Zimling ZG, et al. Cancer Chemother Pharmacol. 2012 Nov;70(5):743-54. doi: 10.1007/s00280-012-1965-0. Epub 2012 Sep 8. Cancer Chemother Pharmacol. 2012. PMID: 22960937 Clinical Trial.

8

High RRM1 Expression Is Associated with Adverse Outcome in Patients with Cisplatin/Vinorelbine-treated Malignant Pleural Mesothelioma.

Zimling ZG, Santoni-Rugiu E, Bech C, Sørensen JB. Zimling ZG, et al. Anticancer Res. 2015 Dec;35(12):6731-8. Anticancer Res. 2015. PMID: 26637889

9

CRISPR/Cas9 Engineering of Adult Mouse Liver Demonstrates That the Dnajb1-Prkaca Gene Fusion Is Sufficient to Induce Tumors Resembling Fibrolamellar Hepatocellular Carcinoma.

Engelholm LH, Riaz A, Serra D, Dagnæs-Hansen F, Johansen JV, Santoni-Rugiu E, Hansen SH, Niola F, Frödin M. Engelholm LH, et al. Gastroenterology. 2017 Dec;153(6):1662-1673.e10. doi: 10.1053/j.gastro.2017.09.008. Epub 2017 Sep 18. Gastroenterology. 2017. PMID: 28923495 Free PMC article.

10

The level of claudin-7 is reduced as an early event in colorectal carcinogenesis.

Bornholdt J, Friis S, Godiksen S, Poulsen SS, Santoni-Rugiu E, Bisgaard HC, Lothe IM, Ikdahl T, Tveit KM, Johnson E, Kure EH, Vogel LK. Bornholdt J, et al. BMC Cancer. 2011 Feb 10;11:65. doi: 10.1186/1471-2407-11-65. BMC Cancer. 2011. PMID: 21310043 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

97 results

Search Page